← Leaderboards
Nadezhda Sabeva
Universidad Central Del Caribe
$373,755
Attributed
$373,755
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.6K · FY2020–22$200K$150K$100K$50K$0
'20
'21
'22
Funding mix
By agency
NIH$373,755 · 1
By mechanism
SC2$373,755 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAffectAlpha-Bungarotoxin ReceptorAlzheimer&AposAnimal ModelAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectAnxietyApoptosisApoptoticAttenuatedBehaviorBehavioralBehavior AssessmentBehavior MonitoringBehavior TestBloodBlood - Brain Barrier AnatomyBrainBrain InjuriesBrain PathologyBrain TissueAcetylcholine
Grant awards (3)
Neuroprotection against Gulf War Illness by an alpha 7 nicotinic Acetylcholine Receptor modulator$124,585
SC2 · FY2022 · NS · contact PI
Neuroprotection against Gulf War Illness by an alpha 7 nicotinic Acetylcholine Receptor modulator$124,585
SC2 · FY2021 · NS · contact PI
Neuroprotection against Gulf War Illness by an alpha 7 nicotinic Acetylcholine Receptor modulator$124,585
SC2 · FY2020 · NS · contact PI